Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,174 | -250,157 | -181,361 | -121,359 | -56,624 |
| Depreciation Amortization | 1,400 | 8,022 | 6,231 | 4,130 | 2,016 |
| Accounts payable and accrued liabilities | -3,806 | 2,203 | -3,250 | 709 | -6,464 |
| Other Working Capital | -19,337 | -18,391 | -22,889 | -12,540 | -16,998 |
| Other Operating Activity | 16,333 | 29,507 | 25,345 | 12,718 | 11,625 |
| Operating Cash Flow | $-76,584 | $-228,816 | $-175,924 | $-116,342 | $-66,445 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,068 | -9,821 | -6,360 | -5,113 | -2,950 |
| Purchase Of Investment | -4,426 | -48,221 | -36,138 | -36,138 | -28,156 |
| Sale Of Investment | 11,233 | 140,470 | 119,000 | 77,622 | 44,078 |
| Investing Cash Flow | $2,739 | $82,428 | $76,502 | $36,371 | $12,972 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 27,606 | 27,606 | 27,606 | 27,606 |
| Debt Repayment | N/A | -1,907 | -1,907 | -1,907 | -1,907 |
| Common Stock Issued | 5,656 | 103,903 | 102,585 | 1,279 | 1,149 |
| Other Financing Activity | 0 | 0 | -3,279 | 0 | 0 |
| Financing Cash Flow | $5,656 | $129,602 | $125,005 | $26,978 | $26,848 |
| Exchange Rate Effect | N/A | -1 | -2 | 0 | N/A |
| Beginning Cash Position | 171,215 | 188,002 | 188,002 | 188,002 | 188,002 |
| End Cash Position | 103,026 | 171,215 | 213,583 | 135,009 | 161,377 |
| Net Cash Flow | $-68,189 | $-16,787 | $25,581 | $-52,993 | $-26,625 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,584 | -228,816 | -175,924 | -116,342 | -66,445 |
| Capital Expenditure | -4,068 | -9,821 | -6,360 | -5,113 | -2,950 |
| Free Cash Flow | -80,652 | -238,637 | -182,284 | -121,455 | -69,395 |